http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0107901-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-00
filingDate 2001-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_458bb0ca1c4004e6f7364c262f5edff8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759cfb8a9da6f3cc670e2f663020f04b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57700b33e564d541d5d7fcb1005eb86d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51edee2553c908b7c9e2b2507d7fa0d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd8c3bdeba84a9eb6f41d3a2f1ba0479
publicationDate 2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0107901-A
titleOfInvention Compound, pharmaceutical composition, method for treating illness, for treating and / or preventing conditions mediated by nuclear receptors, and for the treatment and / or prevention of diabetes and / or obesity, use of a compound, and, method for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance or obesity
abstract "COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS FOR THE TREATMENT OF SICKNESS, FOR THE TREATMENT AND / OR PREVENTION OF CONDITIONS MEDIATED BY NUCLEAR RECEPTORS, AND FOR THE TREATMENT AND / OR PREVENTION OF DIABETES AND / OR OBESITY FOR THE USE OF A COMPOUND, AND TREAT TYPE I DIABETES, TYPE II DIABETES, TOLERANCE TO HARMED GLUCOSE, INSULIN RESISTANCE OR OBESITY ". The present invention relates to compounds of the general formula (I). The compounds are useful in the treatment and / or prevention of conditions mediated by nuclear receptors, in particular peroxisome proliferator activated receptors (PPAR).
priorityDate 2000-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054

Total number of triples: 66.